Ruth Chepngetich, the women's marathon world record holder, has been provisionally suspended after testing positive for a banned diuretic.
She tested positive for Hydrochlorothiazide (HCTZ) from a March 14 sample, according to the Athletics Integrity Unit (AIU).
What happened?
The AIU handles doping cases in international track and field, and Chepngetich's sample was reported to them on April 3.
The results led to Chepngetich being notified and interviewed by the AIU on April 16.
Why it matters for Ruth Chepngetich
Chepngetich had recently won the Chicago Marathon in 2:09:56, taking 1 minute, 57 seconds off the world record on October 13.
This suspension could impact her career, with a possible 2-year ban looming.
What comes next?
Chepngetich has the right to take the case to a disciplinary tribunal, which could determine the length of her suspension.
The tribunal will review the evidence and decide on the appropriate action, with the standard suspension being up to 2 years.
The diuretic HCTZ is used clinically to treat fluid retention and hypertension, but is banned by the World Anti-Doping Agency without an accepted therapeutic use exemption.
Chepngetich's voluntary provisional suspension began on April 19, and she has not commented publicly on the case.
Brett Clothier, the head of the AIU, stated that a provisional suspension is not mandatory in cases of positive tests for diuretics and masking agents.
Chepngetich's case will be closely watched, as she is a prominent figure in the marathon running world.
The Athletics Integrity Unit will continue to investigate and provide updates on the case.
Chepngetich's world record time of 2:09:56 at the Chicago Marathon on October 13 will remain intact, but her future competitions are uncertain.
The World Anti-Doping Agency's rules on diuretics and masking agents are clear, and Chepngetich's positive test has significant implications.
The disciplinary tribunal will play a crucial role in determining Chepngetich's fate, and their decision will be eagerly anticipated.